A longer delay in the diagnosis of erythropoietic protoporphyria (EPP) is associated with a negative impact on patients’ lives,…
Articles by Andrea Lobo, PhD
A case series from Saudi Arabia highlights the challenges sometimes faced by women with acute intermittent porphyria (AIP) in…
A recent case report describes a rare instance of a woman diagnosed with both porphyria cutanea tarda (PCT) and…
COVID-19 triggered an attack of acute intermittent porphyria (AIP) in a 31-year-old woman, according to a report in Japan.
Givlaari (givosiran) safely led to reductions in porphyria attacks and improved the quality of life of people with acute…
Acute hepatic porphyria (AHP) is more commonly seen in women in Denmark, with acute intermittent porphyria (AIP) the the…
Two siblings with a rare form of variegate porphyria (VP) who had skin lesions caused by light or sun…
Alnylam Act, a sponsored genetic testing program developed by Alnylam Pharmaceuticals and now under the management of Preventiongenetics,…
A 15-year-old girl who developed seizures and changes in her mental health status was diagnosed with acute intermittent porphyria…
Multiple testing and specialist appointments are often needed for diagnosing erythropoietic protoporphyria (EPP) and X-linked protoporphyria (XLP), and both conditions…